This document provides an overview of diseases of the ovary, including both non-neoplastic and neoplastic lesions. It discusses common non-neoplastic conditions like follicular cysts and polycystic ovarian disease. It also covers the various types of ovarian tumors, including surface epithelial tumors (serous, mucinous, endometrioid), germ cell tumors, and sex cord-stromal tumors. For each type, it describes the gross and microscopic appearance as well as examples of histopathology slides. Metastatic tumors to the ovaries are also briefly discussed.
Benign ovarian masses include functional cysts and tumors; most are asymptomatic.Most functional cysts and benign tumors are asymptomatic. Sometimes they cause menstrual abnormalities. Hemorrhagic corpus luteum cysts may cause pain or signs of peritonitis, particularly when they rupture. Occasionally, severe abdominal pain results from adnexal torsion of a cyst or mass, usually > 4 cm. Treatment varies depending on the patient's reproductive status.
Explains the inflammatory process of endometrium,its causes and its two clinical variants as acute and chronic endometritis.
Describes the pathology of its two types with histologic perspective.
Benign ovarian masses include functional cysts and tumors; most are asymptomatic.Most functional cysts and benign tumors are asymptomatic. Sometimes they cause menstrual abnormalities. Hemorrhagic corpus luteum cysts may cause pain or signs of peritonitis, particularly when they rupture. Occasionally, severe abdominal pain results from adnexal torsion of a cyst or mass, usually > 4 cm. Treatment varies depending on the patient's reproductive status.
Explains the inflammatory process of endometrium,its causes and its two clinical variants as acute and chronic endometritis.
Describes the pathology of its two types with histologic perspective.
Presentation about the the second most common type of ovarian tumors which have a very unique property of being similar to the testicular germ cell tumors.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Learning Objectives
• At the end of this session, you should know
about
• Non-neoplastic lesions of the ovaries.
• Neoplastic lesions of the ovaries.
4. Manifestations of ovarian diseases:
- Pelvic pain
- Menstrual irregularities ( abnormal pattern of ovarian
hormone secretion).
- Infertility; failure of ovulation (Stein-Leventhal).
- Ovarian mass : either non-neoplastic (cysts) or neoplastic
(cystic or solid).
OVARIAN DISEASES
5. • INFLAMMATORY - OOPHORITIS:
- Inflammation of the ovaries is always secondary to
salpingitis or peritonitis.
- If chronic & bilateral leading to extensive fibrosis &
infertility.
6. NON-NEOPLASTIC OVARIAN
CYSTS
Follicular and Luteal cysts: Common, 1-8 cm in
diameter. They are lined by follicular
(granulosa) cells or luteinized cells.
Asymptomatic, but may rupture, causing
peritoneal reaction & pain.
Chocolate cysts: Blood-filled cysts, due to
endometriosis of the ovaries.
7. Polycystic Ovarian Disease(Stein-Leventhal Syndrome)
(PCOD)
It is important cause of infertility. There is excessive production
of androgens, increase conversion of androgens to estrogen,
insulin resistance, and inappropriate gonadotrophin production by
the pituitary.
Morphology: Ovaries are large, white, many subcortical follicular
cysts(0.5-1 cm.) in diameter, and covered by thickened fibrosed
outer tunica. No corpora lutea (= no ovulation).
Manifestations: Young females with Oligomenorrhea, infertility,
obesity & hirsuitism.
8.
9. Ovarian Endometriotic Cyst
Microscopy
• Foci of endometrial glands and
stroma seen.
• Old/New haemorrhages and
haemosiderin-laden
macrophages
• Surrounding zone of
inflammation and fibrosis
16. OVARIAN TUMORS
- Common forms of neoplasia in women.
- 80-90% of ovarian tumors are benign.
- Most ovarian tumors occur between 20-45 years.
- Ovarian cancer is second MC malignancy of the female genital tract
(after endometrial cancer).
- Most ovarian tumors are derived from surface epithelium, and “CA-
125” is the tumor marker for surface epithelial tumors of the ovary.
- Malignant ovarian tumors present at a late stage, thus are associated
with high mortality rate.
- Known risk factors are nulliparity, family history, and specific
inherited mutations (BRCAI & BRCAII) genes.
17. Tumour types-- a basic classification
Site of origin Types Frequency Age group
Surface epithelial
tumours
1.Serous
2.Mucinous
3.Endometroid
4.Clear cell
5.Brenner
60%-70% 20 years and greater
Germ cell 1.Teratoma
2.Dysgerminoma
3.Endodermal Sinus(Yolk Sac
Tumour)
4.Choriocarcinoma
15%-20% 0 to 25 years and
greater
Sex cord stromal
tumours
1.Granulosa Theca cell
tumours
2.Sertoli-Leydig cell tumours
3.Gynandroblastoma
5%-10% All ages
Miscellaneous 1.Lipid cell tumour
2.Gonadoblastoma
Variable variable
Metastasis Krukenberg tumours 5% variable
18. Serous Ovarian Tumours
GROSS APPEARANCE
• Serous tumours of benign,
borderline and malignant
• type are large and spherical
masses.
• Cut section of benign tumours is
unilocular while larger cysts are
multilocular with daughter loculi
in their walls containing clear
watery fluid.
• Malignant serous tumours have
solid areas in the cystic mass and
may contain exophytic as well as
intracystic papillary
• projections
Papillary serous cystadenoma of the ovary.
Cut surface shows a large unilocular cyst
containing numerous papillary structures
projecting into it (arrow).
19.
20.
21.
22.
23.
24. SEROUS CYSTADENOMA OVARY
MICROSCOPIC APPEARANCE
• The cyst is lined by properly-
oriented low columnar
epithelium.
• The lining cells may be ciliated
and resemble tubal epithelium
Papillary serous cystadenoma of the ovary.
Microscopic features include single layer of
low columnar, at places ciliated, epithelium
lining with pronounced papillary pattern.
25. PAPILLARY SEROUS
CYSTADENOCARCINOMA OVARY
MICROSCOPIC APPEARANCE
• Lining of the cyst is by multilayered
malignant cells having features
such as loss of polarity, presence of
solid sheets of anaplastic epithelial
cells.
• There is definite evidence of
stromal invasion by malignant cells.
• Papillae formations are more
frequent in malignant variety and
may be associated with psammoma
bodies
26.
27.
28. Mucinous Ovarian Tumours
GROSS APPEARANCE
• Mucinous tumours are larger
than serous type.
• They are smooth-surfaced cysts
with characteristic
multiloculations containing thick
and viscid gelatinous fluid.
• Benign tumours have thin wall
and septa which are translucent
while malignant variety has
thickened areas.
Mucinous cystadenoma of the ovary.
Cut surface shows a large,
multiloculated cyst without papillae.
The loculi contain gelatinous material.
29. MUCINOUS CYSTADENOMA OVARY
MICROSCOPIC APPEARANCE
• The cyst is lined by a single layer
of cells having basal nuclei and
apical mucinous vacuoles,
resembling intestinal mucosa.
• There is no invasion or papillae
formation.
The cyst wall and the septa are lined by a
single layer of tall columnar mucin secreting
epithelium with basally-placed nuclei and
large apical mucinous vacuoles.
30.
31. ENDOMETROID TUMOURS
• 20% of all ovarian tumours.
• Majority are carcinomas, if benign forms are
present they are cyst adenofibromas.
• Distinguished from serous and mucinous
tumours by presence of tubular glands bearing
close resemblance to benign or malignant
endometrial glands.
• 30% associated with carcinoma endometrium
and 15% with endometriosis whereas 40%
involve both ovaries.
32. ENDOMETRIOD CARCINOMA
• Gross: presence of both
solid and cystic areas
• Microscopic: Tubular
glands resemble those of
typical endometrial
adenocarcinoma.
33. CLEAR CELL TUMOUR
These are uncommon and aggressive tumours.
Grossly can present in solid and or cystic pattern (figure
solid tumour with cysts and necrosis)
Microscopically: large epithelial cells with abundant clear
cytoplasm.
34. BRENNER TUMOUR
• Uncommon adenofibromas
• Epithelial components– nests of transitional cells
resembling urinary bladder.
• Most are benign,variable size(1cm to 30 cm).
• Gross—solid or cystic
• Microscopic – fibrous stroma resembling normal
ovarian stroma seperated by sharply demarcated
nests of urinary tract, with mucinous glands.
35. BRENNER TUMOUR
• Gross:A sharply
demarcated, yellow-white
fibromatous tumor
occupies a portion of the
sectioned surface of the
ovary.
Microscopically:Nests of
transitional cells, some
containing cysts, lie in a
fibromatous stroma.
36. GERM CELL TUMORS
- 15-20% of all ovarian tumors. It arises from
totipotent germ cells capable of differentiation into
the three germ layers.
- Mostly benign cystic teratomas while Other
tumours are found principally in children
and young adults.
- Homologous to germ cell tumours in male testis.
37. II. GERM CELL TUMORS:
1- Teratoma
2- Dysgerminoma (seminoma ovarii)
3- Yolk sac tumor= Endodermal sinus tumor
4- Embryonal carcinoma (MC mixed with other
types)
5- Choriocarcinoma (MC mixed with other types)
39. TERATOMAS
1-Mature (Benign) Teratoma: MC germ cell tumors of the ovary, cystic (dermoid
cysts), lined by skin & hairs, and filled with sebaceous secretion. There may be
mature cartilage, bone (teeth) & other structures. 10-15% are bilateral. < 1%
undergo malignant transformation (MC sq.c.c.).
2-Immature (Malignant) Teratoma: Rare , solid, bulky, with areas of hemorrhage
and necrosis. It contains embryonic elements of the three germ layers. Age:
adolescent & young women. Grading is based on the amount of immature
neuroepithelium. It causes wide spread extraovarian metatases depending on the
degree of the immaturity of the including tissues.
3- Monodermal (Specialized )Teratomas: differentiate along the line of single
tissue.
Examples:- Strauma ovarii is MC (mature thyroid tissue) – Carcinoid tumor.
40. Benign Cystic Teratoma Ovary
GROSS APPEARANCE
• Benign cystic teratoma is
characteristically a unilocular cyst,
10-15 cm in diameter.
• On sectioning, the cyst is filled with
paste-like sebaceous secretions and
desquamated keratin admixed with
masses of hair.
• The cyst wall is thin and opaque
grey-white.
• The cyst wall also shows a solid
prominence where tissue elements
such as tooth, bone, cartilage and
other odd tissues are present
Benign cystic teratoma (dermoid cyst) of
the ovary. Cut surface shows a large
unilocular cyst containing hair, pultaceous
material and bony tissue.
41.
42.
43.
44. Benign Cystic Teratoma Ovary
MICROSCOPIC APPEARANCE
• Viewing a benign cystic teratoma in
different microscopic fields reveals a
variety of mature differentiated tissues,
producing kaleidoscopic appearance.
• Ectodermal derivatives are most
prominent. The lining of the cyst wall is by
stratified squamous epithelium and its
adnexal structures such as sebaceous
glands, sweat glands and hair follicles.
• Tissues of mesodermal and endodermal
origin are commonly present and include
bronchus, intestinal epithelium, cartilage,
bone, smooth muscle, neural tissue,
salivary gland, retina, pancreas and
thyroid tissue
45.
46.
47. DYSGERMINOMA
• GROSS: Small nodules to
very large size.Cut
surface: yellow white to
gray pink appearance
and are soft and fleshy.
• Microscopic:large vesicular
cells, clear cytoplasm and
well defined boundaries and
centrally placed regular
nuclei.cells in sheets or cords
seperated by scant fibrous
stroma, which has mature
lymphocytes.
48. III. SEX CORD-STROMAL TUMORS:
• 1- Granulosa-Theca cell tumor: secrete
estrogen
• 2- Sertoli-Leydig cell tumor: secrete androgens
• 3- Fibroma: associated with Meig’s syndrome
• 4- Sex cord stromal tumor with annual tubules
• 5- Gynandroblastoma
• 6- Steroid (Lipid)cell tumors
49. METASTATIC TUMOR
- Very common,
- The primary tumors is from abdominal and breast
tumors.
A bilateral metastatic ovarian carcinoma, composed of
mucin-producing signet ring cells, metastasizing from
GIT, mostly from the stomach, it may produce
pseudomyxoma peritonei like well differentiated
appendicial tumors.
Krukenberg tumor
50.
51. HISTOPATHOLOGY OF KRUKENBERG TUMOR
Numerous signet ring cells are present in a highly fibrous stroma, either
individually or in small nests.